• Home
  • Pharmacy Medical Policy Updates

Pharmacy Medical Policy Updates

The following Pharmacy Medical Policy programs have been updated Feb. 1, 2022:

Effective March 1, 2022:

  • Soliris/Ultomiris
  • Winlevi
  • Weight Loss Agents (KS Turnpike Authority groups only)
  • Androgens/Anabolic Steroids
  • Evenity
  • Scenesse
  • Strensiq
  • Sucraid
  • SA Oncology
  • Multiple Sclerosis

Many of our pharmacy medical policies are maintained through our pharmacy benefit manager, Prime Therapeutics.

To find pharmacy medical policies specific to a medication list, please select a medication list at the bottom of our prior authorization page of our website, https://www.bcbsks.com/providers/precertification-prior-authorization

If you have any questions regarding this newsletter, please contact your BCBSKS provider representative/consultant.

Institutional Providers
Professional Providers